• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Polypill Eligibility for Patients with Heart Failure With Reduced Ejection Fraction in South India: A Secondary Analysis of a Prospective, Interrupted Time Series Study.印度南部射血分数降低的心力衰竭患者服用复方制剂的适宜性：一项前瞻性中断时间序列研究的二次分析
J Am Heart Assoc. 2021 Oct 19;10(20):e021676. doi: 10.1161/JAHA.121.021676. Epub 2021 Oct 6.
2
Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.药物治疗对射血分数保留的心力衰竭结局的影响：系统评价和荟萃分析。
Heart. 2018 Mar;104(5):407-415. doi: 10.1136/heartjnl-2017-311652. Epub 2017 Aug 5.
3
Incidence and determinants of left ventricular ejection fraction (LVEF) recovery in heart failure with reduced ejection fraction (HFrEF) of non-ischemic aetiology; a hospital-based prospective longitudinal registry study.非缺血性病因的射血分数降低的心力衰竭（HFrEF）患者左心室射血分数（LVEF）恢复的发生率及决定因素；一项基于医院的前瞻性纵向登记研究。
Indian Heart J. 2025 May-Jun;77(3):188-192. doi: 10.1016/j.ihj.2025.03.016. Epub 2025 Apr 3.
4
The most effective combination of pharmacological therapy for heart failure with reduced ejection fraction: a network meta-analysis of randomized controlled trials.心力衰竭伴射血分数降低的药物治疗最有效组合：一项随机对照试验的网络荟萃分析。
BMC Cardiovasc Disord. 2024 Nov 23;24(1):666. doi: 10.1186/s12872-024-04339-3.
5
Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis.治疗对射血分数保留的心力衰竭患者运动耐量、心功能和死亡率的影响。一项荟萃分析。
J Am Coll Cardiol. 2011 Apr 19;57(16):1676-86. doi: 10.1016/j.jacc.2010.10.057.
6
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
7
Heart failure with reduced ejection fraction polypill implementation strategy in Sri Lanka: design and protocol of a pilot type I hybrid randomised clinical trial.斯里兰卡射血分数降低的心力衰竭多药复方实施方案策略：一项I型混合随机临床试验的设计与方案
BMJ Open. 2025 Jul 15;15(7):e100952. doi: 10.1136/bmjopen-2025-100952.
8
Discrepancy between clinical guidelines and real-world management of heart failure with reduced ejection fraction at University Medical Center Ho Chi Minh City, Vietnam.越南胡志明市大学医学中心射血分数降低的心力衰竭临床指南与实际管理之间的差异。
BMC Cardiovasc Disord. 2025 Jul 14;25(1):506. doi: 10.1186/s12872-025-04964-6.
9
Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review.盐皮质激素受体拮抗剂对舒张功能障碍和射血分数保留的心力衰竭患者心脏结构和功能的影响：一项荟萃分析和系统评价
J Am Heart Assoc. 2015 Oct 12;4(10):e002137. doi: 10.1161/JAHA.115.002137.
10
Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis.射血分数降低的慢性心力衰竭药物治疗疗效的三十年证据：一项网状Meta分析
Circ Heart Fail. 2017 Jan;10(1):e003529. doi: 10.1161/CIRCHEARTFAILURE.116.003529.

引用本文的文献

1
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC.如何处理心力衰竭中的多重用药问题。欧洲心脏病学会心力衰竭协会的临床共识声明。
Eur J Heart Fail. 2025 May;27(5):747-759. doi: 10.1002/ejhf.3642. Epub 2025 Mar 17.
2
Heart failure, the global pandemic: A call to action consensus statement from the global presidential conclave at the platinum jubilee conference of cardiological society of India 2023.心力衰竭，全球大流行：2023 年印度心脏病学会白金禧年会议全球总统峰会的行动共识声明
Indian Heart J. 2024 May-Jun;76(3):147-153. doi: 10.1016/j.ihj.2024.04.004. Epub 2024 Apr 10.
3
Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional Analysis.在 ASIAN-HF 注册研究中，射血分数降低的心力衰竭患者使用多效药丸的资格：一项横断面分析。
Glob Heart. 2023 Jun 15;18(1):33. doi: 10.5334/gh.1215. eCollection 2023.

本文引用的文献

1
Effect of a quality improvement intervention for acute heart failure in South India: An interrupted time series study.印度南部改善急性心力衰竭质量干预的效果：一项中断时间序列研究。
Int J Cardiol. 2021 Apr 15;329:123-129. doi: 10.1016/j.ijcard.2020.12.048. Epub 2020 Dec 24.
2
Improving Care for Heart Failure With Reduced Ejection Fraction-A Potential Polypill-Based Strategy.改善射血分数降低的心力衰竭的治疗——一种基于多效药丸的潜在策略。
JAMA. 2020 Dec 8;324(22):2259-2260. doi: 10.1001/jama.2020.21395.
3
Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry.印度心力衰竭患者的 5 年死亡率和再入院率：特里凡得琅心力衰竭登记研究结果。
Int J Cardiol. 2021 Mar 1;326:139-143. doi: 10.1016/j.ijcard.2020.10.012. Epub 2020 Oct 10.
4
Hospital-based quality improvement interventions for patients with heart failure: a systematic review.基于医院的心力衰竭患者质量改进干预措施：系统评价。
Heart. 2019 Mar;105(6):431-438. doi: 10.1136/heartjnl-2018-314129. Epub 2019 Jan 30.
5
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.用于预防动脉粥样硬化性心血管疾病的固定剂量联合疗法。
Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD009868. doi: 10.1002/14651858.CD009868.pub3.

Polypill Eligibility for Patients with Heart Failure With Reduced Ejection Fraction in South India: A Secondary Analysis of a Prospective, Interrupted Time Series Study.

作者信息

Vijay Aishwarya, Mohanan Padinhare P, Kondal Dimple, Baldridge Abigail, Davies Divin, Devarajan Raji, Unni Govindan, Abdullakutty Jabir, Natesan Syam, Joseph Johny, Jayagopal Pathiyil B, Joseph Stigi, Gopinath Rajesh, Prabhakaran Dorairaj, Huffman Mark D, Agarwal Anubha

机构信息

Department of Medicine Northwestern University Feinberg School of Medicine Chicago IL.

WestFort Hi-Tech Hospital Thrissur Kerala India.

出版信息

J Am Heart Assoc. 2021 Oct 19;10(20):e021676. doi: 10.1161/JAHA.121.021676. Epub 2021 Oct 6.

DOI:10.1161/JAHA.121.021676
PMID:34612082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8751873/
Abstract
摘要